Introduction marine toxin dysiherbaine (DH), and site-directed mutagenesis of KAR subunits to demonstrate preferential Ionotropic glutamate receptors are multimeric channelactivation of only the GluR5 subunits within a heteroforming proteins that exhibit complex physiological bemeric GluR5/KA-2 KAR complex. These results therehavior upon activation by receptor agonists. In AMPA fore support the idea that occupancy of binding sites and kainate receptors (KARs), each subunit within a on individual KAR subunits activates distinct channel receptor complex is thought to have a binding site for conductance and kinetic properties. glutamate formed from two discontinuous regions of the subunit protein (Stern-Bach et al., 1994; Armstrong
Results et al., 1998). Until recently, it has been difficult to determine how the occupancy of binding sites on individual
Dysiherbaine Is a High-Affinity Agonist receptor subunits correlated with the single-channel and for Homomeric Kainate Receptors Dysiherbaine (DH) was characterized previously as a potent epileptogenic amino acid that activates both 
. These results also suggested that the interaction beGluR5 or GluR6 receptors with very high affinity. In our current experiments, we initially determined the activity tween DH and the homomeric receptors was of particularly high affinity, because application of DH desensiof DH on recombinant kainate receptors formed from the subunits GluR5, GluR6, KA-1, and KA-2. We first tized the receptor for extended periods. Figure 1B . The time courses of recovery of A Model for the Action of Dysiherbaine glutamate-activated currents are shown normalized to on GluR5/KA-2 Receptors control amplitudes in Figure 1C . Prior DH application We developed a model to provide a mechanistic explairreversibly and completely occluded any subsequent nation for our results ( Figure 2E ). This model proposes activation of homomeric GluR5 receptors by glutamate that GluR5/KA-2 receptors can be activated at two pharfor at least 45 min. DH produced a similar but less promacologically separable sites. Note that while the model found blockade of glutamate-evoked currents mediated accounts for the actions of DH on heteromeric GluR5/ by GluR6 receptors, which returned to 32% Ϯ 14% of KA-2 receptors, our initial experiments did not allow us pre-DH amplitudes after 30 min (n ϭ 3). In contrast, to come to any conclusions regarding the location of heteromeric GluR6/KA-2 receptors recovered to 90.4% Ϯ sites on the receptor subunits. The proposed relation-6.4% of pre-DH amplitudes 5 min after application of ship between DH and glutamate currents and the occu-DH (n ϭ 5). The recovery of glutamate currents relative pancy of these binding sites is shown in the cartoon to control amplitudes for these kainate receptors at sein Figure 2E . Initial DH binding to both sites results in lected time points after DH application is summarized transient activation (state 1) and desensitization of the in Figure 1D . The most straightforward interpretation of receptor (state 2). Figure 1 (GluR5, GluR6, and GluR6/KA-2), DH elicited in which stably bound DH continues to elicit the steadystate current (e.g., Figure 2D ). complex channel behavior from heteromeric GluR5/ KA-2 receptors (Figure 2 ). Glutamate currents arising
We consider four observations to be supporting evidence for presence of multiple functional sites as shown from GluR5/KA-2 receptors before application of DH ("control") were rapidly desensitizing ( des of 2.1 Ϯ 0.1 in Figure 2E . First, activation of the receptor during the DH steady-state current by glutamate or other agonists ms, n ϭ 20, Figure 2A ). Subsequent application of 10 M DH evoked a desensitizing inward current ( des of does not compete with and displace the high-affinity DH binding that gives rise to the tonic current. Second, 349 Ϯ 85 ms, n ϭ 9). Surprisingly, a long-lasting inward current slowly developed when cells were returned to the high-affinity site can be selectively activated with a very low concentration of DH (100 nM), which produces control solution ( Figure 2B ). The long-lasting current consistently arose after removing DH from the bathing a slowly rising steady-state current without the desensitization apparent at higher agonist concentrations (data solution-regardless of the duration of the DH application. This tonic current had a time course of activation not shown). Third, GluR5/KA-2 receptors can be further activated during the prolonged DH current. Glutamate (after removal of DH) of 25.2 Ϯ 2.9 s (n ϭ 9) and a mean amplitude of 48 Ϯ 11 pA (range 9-199 pA, n ϭ 17), which application in the presence of the stable DH current invariably evoked a small inward current before the onwas 32% Ϯ 5% of the peak glutamate current in the same cells. The current amplitude typically decayed set of desensitization (see Figure 2C , illustrated as element "4" in Figure 2E ). This transient inward current had back to baseline levels after 10 to 20 min. The presence of the DH-induced tonic current, after removal of the a similar voltage-and glutamate concentration dependency as that of the peak nondesensitized current of agonist from the external solution, suggested that the interaction between DH and GluR5/KA-2 receptors was the "naïve" receptor (before DH application). The amplitude of the transient peak current elicited by glutamate very stable.
We then applied agonists, such as glutamate, to was 23% Ϯ 3% of the peak glutamate current before application of DH (n ϭ 14). Fourth, the rate of glutamate GluR5/KA-2 receptors after the development of the DHevoked tonic current. Glutamate elicited a transient indesensitization (before DH application) and the rate of glutamate-induced rapid "positive" displacement to ward current followed by rapid reduction of the tonic DH current to an amplitude similar to the baseline "holding" baseline amplitudes of the tonic DH current were indistinguishable ( values of 2.1 Ϯ 0.2 ms and 2.0 Ϯ 0.2 ms, current before application of DH (i.e., an apparent positive displacement of the current, illustrated by the dotted n ϭ 16 and 15, respectively). We also compared the rates of desensitization and positive displacement of lines in Figure 2C ). The onset of the glutamate-induced reduction in current was rapid ( ϭ 2.1 Ϯ 0.2 ms, n ϭ the DH steady-state current observed with both AMPA (250 M) and DH (10 M) and found that these also were 18). After removal of glutamate, the stable DH current re-emerged with a time course of 22.3 Ϯ 1.8 s (n ϭ 5, not significantly different (AMPA: values of 8.4 Ϯ 1.5 ms for desensitization and 7.0 Ϯ 1.0 ms for displacement, n ϭ Figure 2D ). The tonic current was similar in amplitude before and after application of glutamate. Because glu-4 and 3; DH: values of 349 Ϯ 85 ms for desensitization and 389 Ϯ 93 ms for displacement, n ϭ 9 and 8, respectamate did not attenuate the tonic current (by displacing , then a slower onset of desensitization (state 2). After removal of DH from the bathing solution, it remains tightly bound to the high-affinity site, but not the low-affinity site, resulting in long-lasting steady-state current (state 3). Subsequently, glutamate can bind to the available low-affinity site and cause a transient peak current (state 4) followed by desensitization of the entire receptor complex (state 5). Upon removal of glutamate, the tonic DH current returns as the receptors recover from glutamate desensitization, and the receptor returns to state 3. tively). The high correlation between rates of desensitiIndependent Activation of Subunits in Other Heteromeric Kainate Receptor Complexes zation of naïve receptors and the displacement of the tonic DH currents provides strong support for the hyCan we detect independent activation sites in other heteromeric kainate receptor assemblies? As shown earpothesis that the current displacement arises from receptor desensitization. Thus, we conclude that the tonic lier, GluR6/KA-2 receptors exhibited a much shorter lived interaction with DH ( Figures 1B and 1C) . However, DH current arises from partial activation of the heteromeric receptor complex; binding of agonists at a separe-examination of glutamate-activated currents evoked within 1 min of DH application revealed a small positive rate site further activates then desensitizes the receptors. displacement relative to baseline amplitudes similar to that seen in GluR5/KA-2 receptors ( Figure 3A) . The DHeromeric kainate receptors containing KA-1 subunits exhibited the long-lasting DH current ( Figure 3B ). We found activated GluR6/KA-2 current was detectable only for a brief period of time (Ͻ1 min), presumably reflecting the that, in contrast to GluR5/KA-2 receptors, GluR5/KA-1 receptors were irreversibly inactivated by DH (Figure more rapid dissociation of DH from the high-affinity activation site of this heteromeric receptor. These experi-3B). A prolonged steady-state current was not observed. Less than 10% recovery of glutamate currents was obments demonstrate that DH differentiates multiple activation sites in receptors containing either GluR5 or served for up to 30 min after application of DH (n ϭ 4). We conclude that domains found on the KA-2 subunit, GluR6 subunits with the KA-2 subunit.
The KA-2 subunit is highly homologous to the KA-1 but not the KA-1 subunit, interact with GluR5 subunits to produce DH-induced tonic current. receptor subunit (Werner et Figure 3C ). No CNQX-activated current was
We also made mutations in the KA-2 subunit to determine if interactions with threonine 705, the KA-2 equivaobserved before application of DH (data not shown), nor did application of 0.25% DMSO, the solvent used for lent of asparagine 721 in GluR6, influenced the lower affinity response to glutamate or CNQX. The corre-CNQX, elicit a current after exposure to DH. DNQX, a closely related analog of CNQX, elicited similar currents sponding residue was shown to interact directly with DNQX in a GluR2 S1S2 crystal structure (Armstrong and from GluR5/KA-2 receptors (data not shown). These data therefore show that under some conditions, CNQX Gouaux, 2000). Two substitutions, to an asparagine (KA2(T705N)) or a serine (KA2(T705S)), were made for is an agonist for GluR5/KA-2 receptors. threonine 705, and the resultant KA2 mutants were expressed in combination with GluR5 subunits. The glutaIdentification of Receptor Subunits that Form mate desensitization rate was unaffected by these mutathe High-and Low-Affinity Binding Sites tions, and GluR5/KA2(T705S/N) receptor assemblies for Dysiherbaine responded to DH with the prolonged current after reThe model in Figure 2 proposes two distinct activation moval of the agonist. We tested both combinations of sites in GluR5/KA-2 receptors that can be differentiated heteromeric receptors for sensitivity to CNQX, and by the agonist DH, but does not identify which subunits found that while it elicited a nondesensitizing current within the heteromeric receptor complex contribute the from GluR5/KA-2(T705S) receptors, GluR5/KA-2(T705N) high-and low-affinity binding sites. We next attempted receptors were insensitive to CNQX (n ϭ 4, Figure 4C ). to refine our model by testing the hypothesis that the Receptors comprised of two mutant subunits, R6(N721S)/ two functional binding sites were formed from the S1-KA2(T705N), were similarly insensitive to CNQX (n ϭ 3).
S2 binding domains of the individual kainate receptor
Furthermore, GluR5/KA2(T705N/S) receptors "recovsubunits, as is the case for other AMPA and kainate ered" to the tonic DH current amplitude more rapidly receptor subunits ( 1 s) showed no recovery of glutamateGluR5 and KA-2 subunits differs by at least four orders evoked currents for up to 30 min (3.4% Ϯ 1.8% of control of magnitude, and support the interpretation that the current amplitudes, n ϭ 4). Application of DH to heterofunctionally observed high-and low-affinity sites for DH meric R6(N721S)/KA-2 receptors elicited a desensitizing reside on the GluR5 and KA-2 subunits, respectively. inward current followed by a prolonged steady-state current after removal of DH, similar to GluR5/KA-2 receptors ( Figure 4A ). The time courses of the actions of Discussion DH and glutamate on R6(N721S)/KA-2 receptors were similar to those of GluR5/KA-2 receptors; for example, By virtue of its unusually high affinity for a subset of kainate receptor subunits, DH provides insight into the desensitization rates of R6(N721S)/KA-2 receptors upon application of glutamate or DH ( des of 2.6 Ϯ 0.1 and biophysical operation of this family of ionotropic glutamate receptors. The action of DH on GluR5/KA-2 and 331 Ϯ 52 ms, n ϭ 16 and 11, respectively) were similar to that of GluR5/KA-2 receptors. Finally, in the presence GluR6/KA-2 receptors, together with site-directed mutagenesis of the receptor subunits, provides support for of the stable DH-induced current, CNQX evoked a nondesensitizing current from R6(N721S)/KA-2 receptors a model of receptor function in which individual subunits can be activated within the multimeric receptor com-(23 Ϯ 7 pA, n ϭ 3, Figure 4B ). Similar results were observed when a threonine was substituted for N721 in plex. Thus, agonists for heteromeric kainate receptors . By inference from mRNA expressingle-channel conductance states depended on the number of agonist molecules bound to receptor subsion patterns, many, if not all, neuronal kainate receptors will contain at least one member of each group in heterounits; for example, they observed a higher proportion of openings to larger conductances at higher agonist meric channel complexes (the vast majority of those will contain KA-2 rather than KA-1 subunits). We have concentrations. From these data, they inferred that binding of an agonist molecule to a single receptor subunit identified a compound, DH, which binds to GluR5 and GluR6 subunits with an affinity four orders of magnitude (in a tetrameric complex) produced an associated conductance; as more subunits were activated, the singlegreater than its affinity for KA-2 subunits, which may facilitate the future exploration of the subunit composichannel conductance became larger. Subsequent examination of cerebellar AMPA and kainate receptor tion of neuronal kainate receptors. Other compounds, such as AMPA, have an inverse selectivity profile and single-channel currents by Smith and Howe (Smith and Howe, 2000) supported a similar mode of operation for bind with high affinity to KA-2 subunits but with very low affinity to GluR5 or GluR6 subunits; similarly, AMPA native AMPA receptors. In contrast, kainate receptors did not appear to behave in the same way, which was will elicit currents from heteromeric GluR6/KA-2 receptors but not homomeric GluR6 receptors. By analogy surprising considering their structural and functional similarity to AMPA receptors. Single-channel conducwith our understanding of how we think DH interacts with KARs, AMPA would be selectively activating KA-2 tance states did not correlate with agonist concentration, suggesting that kainate receptors (in cerebellar subunits to produce currents from GluR6/KA-2 receptors. granule neurons) might have a gating mechanism distinct from that of AMPA receptors. In our study, the CNQX provides a third, more unusual example of selective activity on heteromeric GluR5/KA-2 receptors. In differential pharmacological profile of kainate receptor subunits allowed us to demonstrate at a macroscopic this case, the compound acts as an antagonist on one subunit, GluR5, but as an agonist on the partner KA-2 level that these receptors have subunit-associated conductances. Therefore, AMPA and kainate receptors are subunits. The observation that agonist activity was eliminated by changing a single amino acid in the KA-2 likely to share a common gating mechanism.
While our data demonstrate that activation of a subset subunit, T705, as well as earlier results in which CNQX was shown to be a potent agonist on recombinant GluR1 of subunits can occur within a heteromeric receptor complex, other aspects of channel gating, in particular AMPA receptors containing the Lurcher mutation (A636T) (Taverna et al., 2000) , underscore the conclusion desensitization, are dependent on interaction between subunits. The observation that DH produces a sustained that single amino acids critical for receptor gating can determine how receptor ligands are defined pharmacocurrent from GluR5/KA-2 but not homomeric GluR5 receptors demonstrates that the gating of the GluR5 sublogically. We note, however, that the CNQX agonist activity thus far is detectable only under a rather unusual units (in heteromeric receptors) is influenced by the presence of KA-2 subunit. The location of the domains set of conditions-previous activation of partner GluR5 subunits. Two possible explanations may account for on KA-2 that effect the change in GluR5 kinetics is unknown, although it is worth noting that many residues the absence of a CNQX-evoked current before application of DH: first, the antagonist activity of CNQX on that alter desensitization in AMPA and kainate receptors are located in regions that may form intersubunit interGluR5 subunits may "lock" the heteromeric receptors in a state unfavorable for gating, and thus dominate the faces (Armstrong and Gouaux, 2000) . Glutamate desensitization of the DH tonic current in GluR5/KA-2 recepagonist activity on KA-2 subunits. Alternatively, KA-2 subunits in heteromeric receptors may require cooperators demonstrates that agonist binding to one subunit can produce a dominant desensitization of distinct subtive activation of GluR5 subunits before agonist binding can elicit gating. Site-directed mutations on GluR5 or units in the heteromeric complex. Related observations were made in previous studies that examined the phar-KA-2 that selectively eliminate the affinity for CNQX may distinguish between these possibilities. macological properties of GluR5/GluR6 heteromers (Cui
